Long-Term Improvements Observed in Tralokinumab-Treated Patients with Moderate-to-Severe Atopic Dermatitis: an ECZTEND Interim Analysis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 6, p. s59, 2021. DOI: 10.25251/skin.5.supp.59. Disponível em: https://skin.dermsquared.com/skin/article/view/1410. Acesso em: 18 may. 2025.